AVCN Avicanna Inc.

TSX · CA · Healthcare · Drug Manufacturers - Specialty & Generic · avicanna.com

0.1000CAD0.00%Mkt Cap: 9.79M $P/E: —3d ago

Avicanna Inc., a commercial-stage biopharmaceutical company, engages in the research, development, advancement, and commercialization of evidence-based cannabinoid-based products and formulations for medical and pharmace…

Industry Peers

Drug Manufacturers - Specialty & Generic

Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)

$57.06BUSD

TEVA

Teva Pharmaceutical Industries Limited Ordinary Shares

$46.10BUSDP/E 65.9

HLN

Haleon plc American Depositary Shares (Each representing two Ordinary Shares)

Zoetis Inc. Class A Common Stock

$28.80BUSDP/E 11.4

UTHR

United Therapeutics Corporation - Common Stock

$23.23BUSDP/E 19.4

VTRS

Viatris Inc. - Common Stock

$20.22BUSD

SOBI

Swedish Orphan Biovitrum AB (publ)

$14.14BUSDP/E 110.6

NBIX

Neurocrine Biosciences, Inc. - Common Stock

Elanco Animal Health Incorporated Common Stock

$11.06BUSD

RDY

Dr. Reddy's Laboratories Ltd Common Stock

Amneal Pharmaceuticals, Inc. - Class A Common Stock

$7.07BUSDP/E 42.3

ALKS

Alkermes plc - Ordinary Shares

$7.00BUSDP/E 109.9

HIMS

Hims & Hers Health, Inc. Class A Common Stock

$6.77BUSD

LNTH

Lantheus Holdings, Inc. - Common Stock

$6.53BUSDP/E 23.9

KNSA

Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares

$5.83BUSDP/E 76.6

INDV

Indivior Pharmaceuticals, Inc. - Common Stock

$4.21BUSDP/E 12.8

Key Statistics

Company

Market Cap9.79M USD

Enterprise Value16.62M USD

Revenue (TTM)18.44M USD

Gross Profit9.85M USD

Net Income (TTM)-2.07M USD

Revenue/Share0.21 CAD

Last Price0.1000 CAD

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees112

CountryCA

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

ISINCA05368K1003

Valuation

P/E (Trailing)—

P/E (Forward)-1.67

PEG—

EV/EBITDA-7.34

EV/Revenue0.90

P/S0.53

P/B2.94

EPS (TTM)-0.03

EPS (Forward)-0.06

52W Range

0.09502% of range0.2980

52W High0.2980 CAD

52W Low0.0950 CAD

Profitability

Gross Margin53.06%

Oper. Margin-18.86%

EBITDA Margin-12.28%

Profit Margin-11.16%

ROE-100.02%

ROA-13.39%

Growth

Revenue Growth-8.40%

Earnings Growth—

Cash Flow & Leverage

Operating CF-860.25K USD

CapEx (TTM)186.34K USD

FCF Margin-5.34%

FCF Yield-10.05%

Net Debt-22.47K USD

Net Debt/EBITDA0.01

Balance Sheet

Debt/Equity0.00

Current Ratio0.97

Quick Ratio0.45

Book Value/Sh0.03 CAD

Cash/Share0.0010 CAD

Dividends

Fwd Div Rate—

Trail. Div Rate0.00 CAD

Div. Yield0.00%

5Y Avg Yield—

Payout Ratio—

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.134.38M

Float117.65M

Insiders21.29%

Institutions0.00%

Short Interest

Short Ratio0.2d

Short % Out.0.02%

Shares Short24.45K

Short (prev mo.)80.96K

Technical

SMA 500.1208 (-17.2%)

SMA 2000.1522 (-34.3%)

Beta0.34

S&P 52W Chg14.58%

Avg Vol (30d)129.03K

Avg Vol (10d)76.26K

Technical Indicators

RSI (14)36.5

MACD-0.0062

MACD Signal-0.0054

MACD Hist.-0.0008

BB Upper0.1284 CAD

BB Middle0.1110 CAD

BB Lower0.0936 CAD

BB Width31.26%

ATR (14)0.0066 CAD

Vol Ratio (20d)0.35x